TOR Equity Snapshot
BCT Weekly Equity Report
BriaCell Therapeutics Corp.
What the company does
BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., …
What the weekly tape is saying
BCT closed the latest completed week at 3.80 CAD. The 4-week return is -8.0% and the 12-week return is -33.3%. Trend Signal is inactive, Market Dynamics is 0.93. Setup signature: Risk-first tape with a 16/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 7.21 CAD
- Vs Trend Line
- -47.3%
- Fair Value
- 337.3 CAD
- Vs Fair Value
- -98.9%
- 52W High
- 44.10 CAD
- 52W Low
- 3.68 CAD
- Drawdown
- -91.4%
- Range Position
- 0.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- CA Healthcare
- Sector Rank
- 45 of 46
- Sector Percentile
- 2.2%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
CA Healthcare
- Tracked Peers
- 46
- 4W Rank
- 36 of 46
- Avg 1W
- -0.5%
- Avg 4W
- -1.3%
- Trend Breadth
- 34.8%
- Positive MD
- 56.5%
CA Biotechnology
- Tracked Peers
- 12
- 4W Rank
- 9 of 12
- Avg 1W
- 0.1%
- Avg 4W
- -2.9%
- Trend Breadth
- 25.0%
- Positive RS
- 8.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.93
- 4W MD Change
- -27.0%
- Relative Strength
- -72.29
- 4W RS Change
- 5.1%
- Expectation
- Negative
- Probability
- 38.52%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 50.9K
- 13W Average
- 72.1K
- 52W Average
- 60.9K
- Vs 13W
- 0.7x
- Vs 52W
- 0.8x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 11.6%
- 52W Volatility
- 15.0%
- Upside Weeks
- 21
- Downside Weeks
- 31
- Downside Breadth
- 59.6%
- Avg Gain / Loss
- 9.2% / -11.4%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- TOR
- Country
- CA
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- CAD
- Market Cap
- 36.5M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 3.80 CAD | -11.8% | 7.21 CAD | 337.3 CAD | 0.93 | -72.29 | 50.9K | Off |
| 5 Jun 2026 | 4.31 CAD | -14.3% | 7.51 CAD | 344.9 CAD | 1.07 | -70.25 | 54.1K | Off |
| 29 May 2026 | 5.03 CAD | 5.0% | 7.90 CAD | 352.8 CAD | 1.13 | -68.05 | 33.2K | Off |
| 22 May 2026 | 4.79 CAD | 16.0% | 8.24 CAD | 360.6 CAD | 1.17 | -71.30 | 78.2K | Off |
| 15 May 2026 | 4.13 CAD | -27.9% | 8.72 CAD | 368.2 CAD | 1.27 | -76.20 | 165.4K | Off |
| 8 May 2026 | 5.73 CAD | 1.1% | 9.13 CAD | 376.1 CAD | 1.19 | -68.91 | 21.1K | Off |
| 1 May 2026 | 5.67 CAD | 7.0% | 9.52 CAD | 384.5 CAD | 1.06 | -70.67 | 46.0K | Off |
| 24 Apr 2026 | 5.30 CAD | -13.0% | 9.94 CAD | 393.4 CAD | 0.76 | -74.39 | 213.2K | Off |
| 17 Apr 2026 | 6.09 CAD | 3.9% | 10.27 CAD | 402.9 CAD | 0.27 | -73.29 | 34.6K | Off |
| 10 Apr 2026 | 5.86 CAD | 3.9% | 10.49 CAD | 412.3 CAD | -0.05 | -75.44 | 57.2K | Off |
| 3 Apr 2026 | 5.64 CAD | 9.1% | 10.67 CAD | 421.4 CAD | -0.34 | -77.40 | 36.2K | Off |
| 27 Mar 2026 | 5.17 CAD | -9.3% | 10.84 CAD | 430.3 CAD | -0.50 | -79.69 | 41.3K | Off |
| 20 Mar 2026 | 5.70 CAD | -1.2% | 11.02 CAD | 439.8 CAD | -0.47 | -78.26 | 105.7K | Off |
| 13 Mar 2026 | 5.77 CAD | 11.6% | 11.15 CAD | 448.9 CAD | -0.50 | -79.93 | 89.0K | Off |